Cost-effectiveness

1
Cost-effectiveness
2
Cost-effectiveness results in recent studies
conducted by the Hib Initiative
Akumu et al Economic evaluation of delivering
Hib vaccine in routine immunization services in
Kenya, WHO Bulletin, Jul 2007 85 (7) Gessner et
al Vaccine-preventable Haemophilus influenza
type B disease burden and cost-effectiveness of
infant vaccination in Indonesia, Pediatr Infect
Dis J. May 2008 27(5) Griffiths et al
Cost-effectiveness of delivering Hib vaccine as
part of routine childhood immunization services
in Tunisia, Hib Init.9/07 Griffiths et al
Cost-effectiveness of Hib vaccine introduction in
Moldova, Hib Initiative report, Oct. 2007
3
Cost-effectiveness studies of Hib vaccine are
available from 21 different countries
Cost-effectiveness study Cost-effectiveness study
by Hib Initiative

4
Six published studies from Asia and Western
Pacific

• Australia, 1994
• Malaysia, 1999
• Philippines, 2001
• Papua New Guinea, 2002
• Tonga and Fiji, 2003 (Report to WHO, Manila)
• Indonesia, 2008
• Korea, 2008
• And studies are underway in Thailand, India,
  Pakistan and Bangladesh

5
The references

• McIntyre P, Hall J, Leeder S., An economic
  analysis of alternatives for childhood
  immunisation against Haemophilus influenzae type
  b disease, Australian Journal of Public Health,
  18394-400, 1994
• Hussain IHMI, Syed Aljunid, Sofiah A, Ong LC,
  Choo KE, Musa,MN, Teh K, Ng HP, Cost benefit
  analysis of Hib vaccination programme in
  Malaysia, Buletin Kesihatan Masyarakat Jilid,
  vol. 5, 1999
• Limcangco M, Armour C, Salole E, Taylor S.,
  Cost-benefit analysis of a Haemophilus influenzae
  type b meningitis prevention programme in the
  Philippines, Pharmacoeconomics, 19 (4) 391-400,
  2001
• Duke T, Haemophilus influenzae type b meningitis
  how much better is prevention than cure?, PNG Med
  J, Sep-Dec45(3-4)213-218, 2002
• Brinsmead, R, Economic evaluation of Haemophilus
  Influenzae type b and rubella vaccines in Pacific
  Island countries, report prepared for WPRO, May
  2003
• Gessner B, Sedyaningsih E., Griffiths U. et al,
  Vaccine-preventable Haemophilus influenza type b
  (Hib) disease burden and cost-effectiveness of
  infant Hib vaccination in Indonesia, Pediatr
  Infect Dis J. May 2008 27(5)